Serial Number
50102702
Owner
ELIXIRON IMMUNOTHERAPEUTICS INC.Attorney
Michael T. SmithFiling Date
Sep 11, 2026
ELIXIRON Trademark
Serial Number: 50102702
Trademark Classes
Owner Contact Info
16 F.-3, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist.,
Taipei City 115011 R.O.C. , TW
Entity Type: 03
Legal Representation
Correspondence Address
Michael T. Smith Birch Stewart Kolasch & Birch, LLP
2600 Park Tower Drive, Suite 600
Vienna, VA 22180
United States
Trademark Details
Filing Date
September 11, 2026
Registration Date
Not Registered
Goods & Services
Scientific research in the field of immunology; Scientific research in the field of neurodegeneration; Conducting clinical trials for others; Clinical research services; Research and development of antibodies; Scientific and technological services, namely, scientific research, analysis, testing in the field of medical reagents; Culturing of cells for others for scientific research purposes; Research and development of new products for others; Research and development of medicines; Technological research in the field of immunology; Scientific laboratory services; Scientific research; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of clinical research; Medical research in the field of antibodies; Technological research in the field of neurodegeneration
Pharmaceutical preparations for the treatment of Alzheimer’s disease; Pharmaceutical preparations for the treatment of vitiligo; Pharmaceutical preparations for the treatment of hemophagocytic syndrome; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of ALS (Amyotrophic Lateral Sclerosis); Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of immune diseases; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of liver cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for suppressing tumors